Signalling pathways induced by protease-activated receptors and integrins in T cells

被引:39
作者
Bar-Shavit, R
Maoz, M
Yin, YJ
Groysman, M
Dekel, I
Katzav, S [1 ]
机构
[1] Hebrew Univ Jerusalem, Hubert H Humphrey Ctr Expt Med & Canc Res, Hadassah Med Sch, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Dept Oncol, Hadassah Med Sch, IL-91120 Jerusalem, Israel
关键词
D O I
10.1046/j.0019-2805.2001.01351.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent characterization of the thrombin receptor indicates that it plays a role in T-cell signalling pathways. However, little is known regarding the signalling events following stimulation of additional members of the protease-activated receptor (PAR) family, i.e. PAR2 and PAR3. Most of the postligand cascades are largely unknown. Here, we illustrate that in Jurkat T-leukaemic cells, activation of PAR1, PAR2 and PAR3 induce tyrosine phosphorylation of Vav1. This response was impaired in Jurkat T cells deficient in p561ck (JCaM1.6). Activation of PARs also led to an increase in tyrosine phosphorylation of ZAP-70 and SLP-76, two key proteins in T-cell receptor (TCR) signalling. We also demonstrated that p561ck is meaningful for integrin signalling. Thus, JCaM1.6 cells exhibited a marked reduction in their adherence to fibronectin-coated plates, as compared to the level of adherence of Jurkat T cells. While the phosphorylation of Vav1 in T cells is augmented following adhesion, no additional increase was noted following treatment of the adhered cells with PARs. Altogether, we have identified key components in the postligand-signalling cascade of PARs and integrins. Furthermore, we have identified Lck as a critical and possibly upstream component of PAR-induced Vav1 phosphorylation, as well as integrin activation, in Jurkat T cells.
引用
收藏
页码:35 / 46
页数:12
相关论文
共 56 条
  • [21] MIRROR-IMAGE ANTAGONISTS OF THROMBIN-INDUCED PLATELET ACTIVATION BASED ON THROMBIN RECEPTOR STRUCTURE
    HUNG, DT
    VU, TKH
    WHEATON, VI
    CHARO, IF
    NELKEN, NA
    ESMON, N
    ESMON, CT
    COUGHLIN, SR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (02) : 444 - 450
  • [22] ZAP-70 BINDING-SPECIFICITY TO T-CELL RECEPTOR TYROSINE-BASED ACTIVATION MOTIFS - THE TANDEM SH2 DOMAINS OF ZAP-70 BIND DISTINCT TYROSINE-BASED ACTIVATION MOTIFS WITH VARYING AFFINITY
    ISAKOV, N
    WANGE, RL
    BURGESS, WH
    WATTS, JD
    AEBERSOLD, R
    SAMELSON, LE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (01) : 375 - 380
  • [23] Protease-activated receptor 3 is a second thrombin receptor in humans
    Ishihara, H
    Connolly, AJ
    Zeng, DW
    Kahn, ML
    Zheng, YW
    Timmons, C
    Tram, T
    Coughlin, SR
    [J]. NATURE, 1997, 386 (6624) : 502 - 506
  • [24] Beta 1-integrin-mediated cell signaling in T lymphocytes
    Iwata, S
    Ohashi, Y
    Kamiguchi, K
    Morimoto, C
    [J]. JOURNAL OF DERMATOLOGICAL SCIENCE, 2000, 23 (02) : 75 - 86
  • [25] MOLECULAR-CLONING OF SLP-76, A 76-KDA TYROSINE PHOSPHOPROTEIN ASSOCIATED WITH GRB2 IN T-CELLS
    JACKMAN, JK
    MOTTO, DG
    SUN, QM
    TANEMOTO, M
    TURCK, CW
    PELZ, GA
    KORETZKY, GA
    FINDELL, PR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) : 7029 - 7032
  • [26] Functional interactions between the thrombin receptor and the T-cell antigen receptor in human T-cell lines
    Joyce, DE
    Chen, Y
    Erger, RA
    Koretzky, GA
    Lentz, SR
    [J]. BLOOD, 1997, 90 (05) : 1893 - 1901
  • [27] Katzav S, 1995, CRIT REV ONCOGENESIS, V6, P87
  • [28] LOSS OF THE AMINO-TERMINAL HELIX-LOOP-HELIX DOMAIN OF THE VAV PROTOONCOGENE ACTIVATES ITS TRANSFORMING POTENTIAL
    KATZAV, S
    CLEVELAND, JL
    HESLOP, HE
    PULIDO, D
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (04) : 1912 - 1920
  • [29] KATZAV S, 1994, J BIOL CHEM, V269, P32579
  • [30] VAV, A NOVEL HUMAN ONCOGENE DERIVED FROM A LOCUS UBIQUITOUSLY EXPRESSED IN HEMATOPOIETIC-CELLS
    KATZAV, S
    MARTINZANCA, D
    BARBACID, M
    [J]. EMBO JOURNAL, 1989, 8 (08) : 2283 - 2290